Development and pre-clinical assessment of a first-in-class small molecule inhibitor of FLIP

被引：2
|
作者：
Higgins, Catherine A. [1 ]
Fox, Jennifer [1 ]
Majkut, Joanna [1 ]
Fiedler, Greti E. [1 ]
Roberts, Jamie [1 ]
Humphreys, Luke [1 ]
Boffey, Ray J. [2 ]
Perrior, Trevor R. [2 ]
Harrison, Timothy [1 ]
Longley, Daniel B. [1 ]
机构：
[1] Queens Univ Belfast, Belfast, Antrim, North Ireland
[2] Domainex Ltd, Saffron Walden CB10 1XL, Essex, England
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
基金：
英国惠康基金;
关键词：
D O I：
10.1158/1538-7445.AM2019-382
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
382
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Development and pre-clinical assessment of a first-in-class small molecule inhibitor of FLIP for treatment of NSCLC and CRC
    Higgins, C. A.
    Majkut, J.
    Humphreys, L.
    Fox, J.
    Espona-Fiedler, M.
    Malik, A.
    Nemeth, Z.
    Blurton, P.
    Boffey, R. J.
    Perrior, T. R.
    Haigh, D.
    Harrison, T.
    Longley, D. B.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S6 - S6
  • [2] Development and preclinical assessment of a first-in-class small molecule inhibitor of FLIP
    Majkut, Joanna
    Higgins, Catherine
    Fox, Jennifer
    Fiedler, Greti E.
    Harrison, Timothy
    Longley, Daniel B.
    CANCER RESEARCH, 2017, 77
  • [3] Development and preclinical assessment of a first-in-class small-molecule inhibitor of FLIP
    Higgins, Catherine A.
    Majkut, Joanna
    Fox, Jennifer
    Humphreys, Luke
    Fiedler, Greti Espona
    Boffey, Ray J.
    Perrior, Trevor R.
    Haigh, David
    Harrison, Timothy
    Longley, Daniel B.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [4] Development and preclinical assessment of a first-in-class small molecule inhibitor of the major cell death regulator protein FLIP
    Majkut, Joanna
    Higgins, Catherine
    Maliki, Adnan
    Nemeth, Zsusannah
    Blurton, Peter
    Boffey, Ray
    Perrior, Trevor R.
    Johnston, Patrick G.
    Haigh, David
    Harrison, Timothy
    Longley, Daniel B.
    CANCER RESEARCH, 2015, 75
  • [5] Development and characterization of a first-in-class small molecule inhibitor of PELP1
    Altwegg, Kristin A.
    Viswanadhapalli, Suryavathi
    Mann, Monica
    Pratap, Uday P.
    Li, Mengxing
    Liu, Junhao
    Luo, Yiliao
    Sareddy, Gangadhara R.
    Vankayalapati, Hariprasad
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2020, 80 (04)
  • [6] Pre-clinical development of a first-in-class heat shock protein-based personalized cancer vaccine
    Khattar, M.
    Morin, B.
    Uduman, M.
    Zelin, J.
    Stein, R.
    Exley, M.
    Castle, J.
    Levey, D.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 221 - 221
  • [7] Development and preclinical evaluation of unique first-in-class small molecule inhibitors of the anti-apoptotic protein FLIP.
    Higgins, Catherine A.
    Fox, Jennifer
    Roberts, Jamie
    Doherty, Declan
    Perrior, Trevor
    Boffey, Ray
    Harrison, Tim
    Longley, Daniel B.
    CANCER RESEARCH, 2021, 81 (13)
  • [8] Pre-Clinical Activity of the Novel, First-in-Class p97 Inhibitor, CB-5083, in Multiple Myeloma
    Aftab, Blake T.
    Anderson, Daniel J.
    Le Moigne, Ronan
    Djakovic, Stevan
    Dhimolea, Eugen
    Murnane, Megan
    King, Emily
    Rice, Julie
    Wong, Steve
    Kumar, Brajesh
    Valle, Eduardo
    Menon, Mary-Kamala
    von Soly, Szerenke Kiss
    Wang, Jinhai
    Yao, Bing
    Soriano, Ferdie
    Kampmann, Martin
    Alcost-Alvear, Diego
    Chesi, Marta
    Bergsagel, Leif
    Yakes, F. Michael
    Zhou, Han-Jie
    Wustrow, David
    Martin, Thomas G.
    Wolf, Jeffrey L.
    Mitsiades, Constantine S.
    Rolfe, Mark
    BLOOD, 2014, 124 (21)
  • [9] Development of a First-in-Class Small-Molecule Inhibitor of the C-Terminal Hsp90 Dimerization
    Bhatia, Sanil
    Spanier, Lukas
    Bickel, David
    Dienstbier, Niklas
    Woloschin, Vitalij
    Vogt, Melina
    Pols, Henrik
    Lungerich, Beate
    Reiners, Jens
    Aghaallaei, Narges
    Diedrich, Daniela
    Frieg, Benedikt
    Schliehe-Diecks, Julian
    Bopp, Bertan
    Lang, Franziska
    Gopalswamy, Mohanraj
    Loschwitz, Jennifer
    Bajohgli, Baubak
    Skokowa, Julia
    Borkhardt, Arndt
    Hauer, Julia
    Hansen, Finn K.
    Smits, Sander H. J.
    Jose, Joachim
    Gohlke, Holger
    Kurz, Thomas
    ACS CENTRAL SCIENCE, 2022, 8 (05) : 636 - 655
  • [10] First-in-class small molecule potentiators of cancer virotherapy
    Mark H. Dornan
    Ramya Krishnan
    Andrew M. Macklin
    Mohammed Selman
    Nader El Sayes
    Hwan Hee Son
    Colin Davis
    Andrew Chen
    Kerkeslin Keillor
    Penny J. Le
    Christina Moi
    Paula Ou
    Christophe Pardin
    Carlos R. Canez
    Fabrice Le Boeuf
    John C. Bell
    Jeffrey C. Smith
    Jean-Simon Diallo
    Christopher N. Boddy
    Scientific Reports, 6
12345